Serum SP70 is a sensitive predictor of chemotherapy response in patients with advanced nonsmall cell lung cancer

Abstract SP70 is a novel tumor biomarker in patients with nonsmall cell lung cancer (NSCLC). However, its role as a marker for predicting the response to chemotherapy for patients with advanced NSCLC has not been investigated. A total of 152 patients were enrolled. Serum SP70, carcinoembryonic antig...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jingping Liu, Wei Zhang, Min Gu, Yazhou Ji, Lu Yang, Xiangjun Cheng, Xuelian Xiao, Jian Xu, Chunrong Gu, Jiexin Zhang, Shichang Zhang, Dan Chen, Shiyang Pan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2018-07-01
coleção:	Cancer Medicine
Assuntos:	clinical efficacy nonsmall cell lung cancer progression‐free survival SP70 tumor markers
Acesso em linha:	https://doi.org/10.1002/cam4.1555
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!